CD38 pretargeted RIT of B-cell tumors

Autor Buchsbaum, Donald J.
Vydáno v Blood (2018)

Monoclonal antibodies in the treatment of pancreatic cancer

Autor Huang, Zhi-Qiang, Buchsbaum, Donald J
Vydáno 2009

Cancer Treatment with Gene Therapy and Radiation Therapy

Autor Kaliberov, Sergey A., Buchsbaum, Donald J.
Vydáno 2012

Will Detection of MicroRNA Biomarkers in Blood Improve the Diagnosis and Survival of Patients With Pancreatic Cancer?

Autor Buchsbaum, Donald J., Croce, Carlo M.
Vydáno 2014

Experimental virotherapy of chemoresistant pancreatic carcinoma using infectivity-enhanced fiber-mosaic oncolytic adenovirus

Autor Kaliberov, Sergey A., Kaliberova, Lyudmila N., Buchsbaum, Donald J., Curiel, David T.
Vydáno 2014

Therapy of Head and Neck Squamous Cell Carcinoma with Replicative Adenovirus Expressing Tissue Inhibitor of Metalloproteinase-2 and Chemoradiation

Autor McNally, Lacey R., Rosenthal, Eben L., Zhang, Wenyue, Buchsbaum, Donald J.
Vydáno 2008

Epigenetic therapy for the treatment of epithelial ovarian cancer: A clinical review

Autor Smith, Haller J., Straughn, J. Michael, Buchsbaum, Donald J., Arend, Rebecca C.
Vydáno v Gynecol Oncol Rep (2017)

Modulation of antitumor immunity with histone deacetylase inhibitors

Autor McCaw, Tyler R, Randall, Troy D, Forero, Andres, Buchsbaum, Donald J
Vydáno v Immunotherapy (2017)

Ovarian cancer stem cells: Can targeted therapy lead to improved progression-free survival?

Autor Walters Haygood, Christen L, Arend, Rebecca C, Straughn, J Michael, Buchsbaum, Donald J
Vydáno 2014

Journey of TRAIL from Bench to Bedside and its Potential Role in Immuno-Oncology

Autor Naoum, George E., Buchsbaum, Donald J., Tawadros, Fady, Farooqi, Ammad, Arafat, Waleed O.
Vydáno v Oncol Rev (2017)

A new drug delivery method of bispecific ligand-directed toxins that reduces toxicity and promotes efficacy in a model of orthotopic pancreatic cancer

Autor Oh, Seunguk, Stish, Brad J, Vickers, Selwyn M., Buchsbaum, Donald J., Vallera, Daniel A.
Vydáno 2010

Combined modality therapy with TRAIL or agonistic death receptor antibodies

Autor Amm, Hope M, Oliver, Patsy G, Lee, Choo Hyung, Li, Yufeng, Buchsbaum, Donald J
Vydáno 2011

Survivin a radiogenetic promoter for glioblastoma viral gene therapy independently from CArG motifs

Autor Naoum, George E., Zhu, Zeng B., Buchsbaum, Donald J., Curiel, David T., Arafat, Waleed O.
Vydáno v Clin Transl Med (2017)

MOLECULAR TARGETED THERAPIES FOR PANCREATIC CANCER

Autor Borja-Cacho, Daniel, Jensen, Eric Hans, Saluja, Ashok Kumar, Buchsbaum, Donald J, Vickers, Selwyn Maurice
Vydáno 2008

In vivo Efficacy of Marimastat and Chemoradiation in Head and Neck Cancer Xenografts

Autor Skipper, Joni B., McNally, Lacey R., Rosenthal, Eben L., Wang, Wenquan, Buchsbaum, Donald J.
Vydáno 2009

Mechanisms of drug sensitization to TRA-8, an agonistic death receptor 5 antibody, involve modulation of the intrinsic apoptotic pathway in human breast cancer cells

Autor Amm, Hope M., Zhou, Tong, Steg, Adam D., Kuo, Huichien, Li, Yufeng, Buchsbaum, Donald J.
Vydáno 2011

Multi-targeted therapy of cancer by niclosamide: a new application for an old drug

Autor Li, Yonghe, Li, Pui Kai, Roberts, Michael J., Arend, Rebecca, Samant, Rajeev S., Buchsbaum, Donald J.
Vydáno 2014

Dynamic Contrast Enhanced Magnetic Resonance Imaging of an Orthotopic Pancreatic Cancer Mouse Model

Autor Kim, Hyunki, Samuel, Sharon, Totenhagen, John W., Warren, Marie, Sellers, Jeffrey C., Buchsbaum, Donald J.
Vydáno v J Vis Exp (2015)

Calmodulin Binding to Death Receptor 5-mediated Death-inducing Signaling Complex in Breast Cancer Cells

Autor Fancy, Romone M., Kim, Harrison, Zhou, Tong, Zinn, Kurt R., Buchsbaum, Donald J., Song, Yuhua
Vydáno v J Cell Biochem (2017)

Calmodulin antagonist enhances DR5-mediated apoptotic signaling in TRA-8 resistant triple negative breast cancer cells

Autor Fancy, Romone M., Kim, Harrison, Napier, Tiara, Buchsbaum, Donald J., Zinn, Kurt R., Song, Yuhua
Vydáno v J Cell Biochem (2018)